Manja Reimann1, Walthard Vilser, Matthias Gruber, Stefan R Bornstein, Tjalf Ziemssen. 1. Autonomic and Neuroendocrinological Laboratory Dresden, Department of Neurology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Fetscherstr. 74, 01307, Dresden, Germany, manja.reimann@uniklinikum-dresden.de.
Abstract
AIMS/HYPOTHESIS: Insulin may link metabolic disorders to retinal microvascular pathology. The aim of the present study was to investigate the impact of early insulin resistance on retinal microcirculation. METHODS: Retinal diameter responses to flicker-light stimulation were investigated in 81 clinically healthy participants (32 ± 6 years [mean ± SD], 59% women) who were recruited according to their BMI. All participants underwent an OGTT and euglycaemic-hyperinsulinaemic clamp (40 mU/m(2) · min(-1) insulin dose). After stratification by low and high insulin sensitivity based on a clamp-derived glucose disposal rate of ≤ or >4.9 mg/kg body mass, respectively, baseline retinal diameters and their relative changes to flicker stimulation were compared while controlling for mean arterial pressure, BMI and sex. RESULTS: The arterial vasodilator response at the end of flicker stimulation (p = 0.044) and the area under the arterial reaction curve during flicker stimulation (p = 0.015) were significantly higher in individuals with low vs high insulin sensitivity. Vasodilatory responses of retinal veins to flicker stimulation and baseline retinal diameters did not differ between insulin-sensitive and insulin-resistant participants (p > 0.05). In a stepwise linear regression analysis, fasting insulin remained the only predictor of the arterial vasodilator response to flicker-light (p < 0.01). Waist circumference also contributed, although to a lesser extent, to the arterial vasodilator response (p = 0.023). CONCLUSIONS/ INTERPRETATION: Insulin sensitivity is an important determinant of retinal microvascular function. We propose that the elevated arterial flicker response in insulin-resistant states is a result of higher circulating insulin levels.
AIMS/HYPOTHESIS: Insulin may link metabolic disorders to retinal microvascular pathology. The aim of the present study was to investigate the impact of early insulin resistance on retinal microcirculation. METHODS: Retinal diameter responses to flicker-light stimulation were investigated in 81 clinically healthy participants (32 ± 6 years [mean ± SD], 59% women) who were recruited according to their BMI. All participants underwent an OGTT and euglycaemic-hyperinsulinaemic clamp (40 mU/m(2) · min(-1) insulin dose). After stratification by low and high insulin sensitivity based on a clamp-derived glucose disposal rate of ≤ or >4.9 mg/kg body mass, respectively, baseline retinal diameters and their relative changes to flicker stimulation were compared while controlling for mean arterial pressure, BMI and sex. RESULTS: The arterial vasodilator response at the end of flicker stimulation (p = 0.044) and the area under the arterial reaction curve during flicker stimulation (p = 0.015) were significantly higher in individuals with low vs high insulin sensitivity. Vasodilatory responses of retinal veins to flicker stimulation and baseline retinal diameters did not differ between insulin-sensitive and insulin-resistant participants (p > 0.05). In a stepwise linear regression analysis, fasting insulin remained the only predictor of the arterial vasodilator response to flicker-light (p < 0.01). Waist circumference also contributed, although to a lesser extent, to the arterial vasodilator response (p = 0.023). CONCLUSIONS/ INTERPRETATION:Insulin sensitivity is an important determinant of retinal microvascular function. We propose that the elevated arterial flicker response in insulin-resistant states is a result of higher circulating insulin levels.
Authors: Thomas Forst; Matthias M Weber; Michael Mitry; Thomas Schöndorf; Senait Forst; Mukadar Tanis; Andreas Pfützner; Georg Michelson Journal: J Diabetes Sci Technol Date: 2012-01-01
Authors: A Uruska; A Araszkiewicz; D Zozulinska-Ziolkiewicz; P Uruski; B Wierusz-Wysocka Journal: Exp Clin Endocrinol Diabetes Date: 2010-04-06 Impact factor: 2.949
Authors: Jonathan E Noonan; Gregory J Dusting; Thanh T Nguyen; Alicia J Jenkins; Ryan E K Man; William J Best; Daniel A Dias; Nirupama S Jayasinghe; Ute Roessner; Ecosse L Lamoureux Journal: Invest Ophthalmol Vis Sci Date: 2014-10-08 Impact factor: 4.799
Authors: Steven E Stern; Ken Williams; Eleuterio Ferrannini; Ralph A DeFronzo; Clifton Bogardus; Michael P Stern Journal: Diabetes Date: 2005-02 Impact factor: 9.461
Authors: Jie Ding; Khin Lay Wai; Kevin McGeechan; M Kamran Ikram; Ryo Kawasaki; Jing Xie; Ronald Klein; Barbara B K Klein; Mary Frances Cotch; Jie Jin Wang; Paul Mitchell; Jonathan E Shaw; Kayama Takamasa; A Richey Sharrett; Tien Y Wong Journal: J Hypertens Date: 2014-02 Impact factor: 4.844
Authors: Guido T Dorner; Gerhard Garhofer; Barbara Kiss; Elzbieta Polska; Kaija Polak; Charles E Riva; Leopold Schmetterer Journal: Am J Physiol Heart Circ Physiol Date: 2003-05-15 Impact factor: 4.733
Authors: Ronald Klein; Barbara E K Klein; Scot E Moss; Tien Y Wong; Larry Hubbard; Karen J Cruickshanks; Mari Palta Journal: Arch Ophthalmol Date: 2004-01